Abstract

The present invention is directed toward a recombinant virus particle vaccine comprising a recombinant molecule packaged in an alphavirus coat. A preferred recombinant molecule of the present invention comprises a nucleic acid sequence that encodes a protective compound (e.g. a protective protein or a protective RNA) capable of protecting an animal from a disease, such that the nucleic acid sequence is operatively linked to a packaging-defective alphavirus expression vector that is capable of directing replication and transcription of the recombinant molecule. The invention also includes methods to produce and use such vaccines to protect animals from disease, particularly from disease caused by protozoan parasites such as Toxoplasma gondii, helminth parasites, ectoparasites, fungi, bacteria, or viruses.


Claims
Owners (US)
Download PDF
Document Preview
Document History
  • Publication: Jun 16, 1998
  • Application: Jan 19, 1995
    US US 37523595 A
  • Priority: Jan 19, 1995
    US US 37523595 A
  • Priority: Feb 8, 1993
    US US 1541493 A

Download Citation


Sign in to the Lens

Feedback